Related Experiment Video
Updated: Aug 6, 2026
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms
Gregory Lizée1, Laszlo G Radvanyi, Willem W Overwijk
1Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. glizee@mdanderson.org
Abstract:
Although numerous immunotherapeutic strategies have been studied in patients with cancer, consistent induction of clinical responses remains a formidable challenge. Cancer vaccines are often successful at generating elevated numbers of tumor-specific T lymphocytes in peripheral blood, however, despite this, tumors usually continue to grow unabated. Recent evidence suggests that endogenous regulatory cells, known to play a major role in the induction of immune tolerance to self and prevention of autoimmunity, as well as suppressive myeloid cells invoked in the tumor-bearing state, may be largely responsible for preventing effective antitumor immune responses. This review will focus on the major regulatory cell subtypes, including CD4(+)CD25(+) T-regulatory cells, type 1 regulatory T cells, natural killer T cells, and immature myeloid cells. Studies in humans and in animal models have shown a role for all of these cells in tumor progression, although the mechanisms by which they act to suppress immunity remain largely undefined. Elucidation of the dominant molecular mechanisms mediating immune suppression in vivo will allow more precise targeting of the relevant regulatory cell populations, as well as the development of novel strategies and clinical reagents that will directly block molecules that induce the suppression of antitumor immunity.
Insights
Cancer vaccines often fail to eliminate tumors because regulatory cells suppress immune responses. Targeting these suppressive cells, including T-regulatory cells and myeloid cells, is crucial for effective cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Immunotherapy, including cancer vaccines, shows limited clinical success in patients with cancer.
- While vaccines can increase tumor-specific T lymphocytes, tumors often continue to grow.
- Endogenous regulatory cells and suppressive myeloid cells are implicated in preventing effective antitumor immunity.
Purpose of the Study:
- This review focuses on major regulatory cell subtypes involved in immune suppression.
- It aims to highlight their role in tumor progression and immune evasion.
- The goal is to understand mechanisms for developing targeted therapies.
Main Methods:
- Review of existing studies in human and animal models.
- Focus on regulatory cell subtypes: CD4(+)CD25(+) T-regulatory cells, type 1 regulatory T cells, natural killer T cells, and immature myeloid cells.
- Analysis of their role in tumor progression and immune suppression.
Main Results:
- Multiple regulatory cell subtypes, including T-regulatory cells and immature myeloid cells, are implicated in tumor progression.
- These cells contribute to the suppression of antitumor immune responses.
- The precise mechanisms of immune suppression by these cells are not fully understood.
Conclusions:
- Understanding the molecular mechanisms of immune suppression is key.
- This knowledge will enable precise targeting of regulatory cell populations.
- Novel strategies and reagents can be developed to block immune suppression and enhance antitumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses
02:17The Tumor Microenvironment
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...